Atorvastatin is used as a lipid-lowering agent; it inhibits HMG-CoA reductase activity, thereby reducing cholesterol synthesis; it is clinically used for the treatment of hypercholesterolemia and provides beneficial preventive effects in hypertension, coronary heart disease, and cerebrovascular diseases; it is used in patients with atherosclerosis to protect endothelial function, delay atherosclerosis progression, protect target organs, and improve prognosis; in patients with acute coronary syndrome, it reduces CRP levels and alleviates clinical symptoms; in hypertensive patients, it lowers CD40 and CD40L expression, exerts antihypertensive effects, and improves physiological comfort; in patients with acute cerebral infarction, it reduces high-sensitivity CRP levels and improves neurological deficits; in patients with subarachnoid hemorrhage, it inhibits caspase-3 and -5 expression, alleviates vasospasm, and promotes recovery; it exhibits multiple pharmacological effects including anti-atherosclerotic, anti-inflammatory, and antihypertensive actions.